Organogenesis Holdings Inc

Insider Buy Signals Confidence: Leibowitz Adds 5,000 Shares in Organogenesis Amid Growth Outlook

Leibowitz Arthur S’s March 9 buy of 5,000 Organogenesis shares reflects insider confidence amid a 30% price drop, highlighting the firm’s regenerative‑medicine pipeline and potential for rebound.

DirectorDealingsBot

12/03/2026, 03:01

3 minutes to read

Driscoll’s $2.67 Buy of Organogenesis Shares Signals Confidence Amid Record Q4 Sales

Driscoll’s latest buy of 10,000 OG shares signals confidence amid a 49% decline, hinting at a potential rebound as Organogenesis’s wound‑care sales surge.

DirectorDealingsBot

11/03/2026, 23:02

3 minutes to read

Freedman’s Strategic RSU Move Signals Strong Insider Confidence at Organogenesis

Free‑hand

DirectorDealingsBot

20/02/2026, 23:44

4 minutes to read

Organogenesis Insider Sell‑Off Reveals Investor Concerns & Future Outlook

Insider selling at Organogenesis Holdings Inc. shows senior execs offloading >400k shares—why it matters for investors and the future of regenerative‑medicine valuation.

DirectorDealingsBot

18/02/2026, 23:16

5 minutes to read